OBJECTIVE: To measure the T1 times in blood after the administration of the intravascular contrast agent gadofosveset trisodium in humans. MATERIALS AND METHODS: In a pilot study for parameter optimization, the T1-shortening induced by the injection of a single dose (0.03 mmol/kg body weight) of the MR contrast agent Vasovist (Bayer Schering Pharma AG) was measured at B0=1.5 T as a function of time. In four sessions, T1 measurements were performed in the carotid vein of 9 volunteers up to 30 min after injection. T1 times were measured using a segmented saturation recovery turboFLASH (SSRTFL) pulse sequence with 7 different saturation recovery delay times in a total acquisition time of 20 s. RESULTS: The SSRTFL measurements showed T1 times of about 100 ms immediately after injection, which gradually increased to 175 ms at 30 min. The time curve of the R1=1/T1 averaged over all volunteers could be described with an exponential decay with a time constant T=330+/-65 s and an amplitude DeltaR1=4.1+/-0.3 s(-1), and a constant offset of R1(0)=5.7+/-0.2 s(-1). Mean relaxation values are in excellent agreement with theoretical predictions. CONCLUSION: An analytical expression for the initial T1-shortening of Vasovist was derived which can now be used for optimization of the pulse sequence parameters in clinical studies.
OBJECTIVE: To measure the T1 times in blood after the administration of the intravascular contrast agent gadofosveset trisodium in humans. MATERIALS AND METHODS: In a pilot study for parameter optimization, the T1-shortening induced by the injection of a single dose (0.03 mmol/kg body weight) of the MR contrast agent Vasovist (Bayer Schering Pharma AG) was measured at B0=1.5 T as a function of time. In four sessions, T1 measurements were performed in the carotid vein of 9 volunteers up to 30 min after injection. T1 times were measured using a segmented saturation recovery turboFLASH (SSRTFL) pulse sequence with 7 different saturation recovery delay times in a total acquisition time of 20 s. RESULTS: The SSRTFL measurements showed T1 times of about 100 ms immediately after injection, which gradually increased to 175 ms at 30 min. The time curve of the R1=1/T1 averaged over all volunteers could be described with an exponential decay with a time constant T=330+/-65 s and an amplitude DeltaR1=4.1+/-0.3 s(-1), and a constant offset of R1(0)=5.7+/-0.2 s(-1). Mean relaxation values are in excellent agreement with theoretical predictions. CONCLUSION: An analytical expression for the initial T1-shortening of Vasovist was derived which can now be used for optimization of the pulse sequence parameters in clinical studies.
Authors: Martin Rohrer; Hans Bauer; Jan Mintorovitch; Martin Requardt; Hanns-Joachim Weinmann Journal: Invest Radiol Date: 2005-11 Impact factor: 6.016
Authors: T M Grist; F R Korosec; D C Peters; S Witte; R C Walovitch; R P Dolan; W E Bridson; E K Yucel; C A Mistretta Journal: Radiology Date: 1998-05 Impact factor: 11.105
Authors: Maddalena Strumia; Wilfried Reichardt; Ori Staszewski; Dieter Henrik Heiland; Astrid Weyerbrock; Irina Mader; Michael Bock Journal: MAGMA Date: 2016-04-20 Impact factor: 2.310
Authors: Fabio S Raman; Marcelo S Nacif; George Cater; Neville Gai; Jacquin Jones; Debiao Li; Christopher T Sibley; Songtao Liu; David A Bluemke Journal: Int J Cardiovasc Imaging Date: 2013-03-21 Impact factor: 2.357
Authors: Marcelo Souto Nacif; Fabio S Raman; Neville Gai; Jacquin Jones; Rob J van der Geest; Christopher T Sibley; Songtao Liu; A Bluemke David Journal: Radiol Bras Date: 2018 Jan-Feb